Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Saturday
Mar 13th
Home arrow Farmavita.Net Journal arrow Pricing & Reimbursement Models
Pricing & Reimbursement Models Print E-mail
Events - Events
Written by NextLevel Pharma   
Wednesday, 27 January 2010

risksharingnextlevel.gif

2nd Annual Pharmaceutical

Risk-Sharing & Value-Based Pricing & Reimbursement Models

April 15-16, 2010 - Vienna, Austria

There is clearly an increasing need for more innovative pricing and reimbursement agreements to help to balance the often conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA), physicians and patients. The industry faces a sustained increase in the cost of healthcare and an ever-increasing range of expensive drugs and technologies available as potential therapies.

Clearly, difficult choices need to be made by payers and HTAs about which products receive funding from increasingly restricted healthcare budgets, especially with often insufficient clinical and real-life evidence available. In terms of innovative agreements, more manufacturers, in more countries, are proposing risk-sharing and value-based schemes more often.

NextLevel Pharma has organised a unique meeting that will be focused purely on risk-sharing and value-based pricing schemes and will provide experts theories and practical case studies of successful models.

Why Attend?

  • Understand the opportunities, obstacles and challenges in designing and implementing innovative agreements.
  • Find out when risk-sharing & value-based agreements are required and how they can be designed to satisfy all stakeholders to gain market access.
  • Understand whether or not the turbulent macroeconomic environment will increase payer motivation for flexible agreements.
  • Obtain the best and most focused picture of risk-sharing and value-based pricing models today.
  • Learn how drug effectiveness is being demonstrated in different regions.
  • Understand the best ways to communicate value and achieve maximum patient and market access.
  • Hear the perspectives of all stakeholder groups: Payers, regulators, insurers, health economists and the pharmaceutical industry.
  • Discover how payers are evaluating conditional reimbursement agreements.

To request the full agenda please follow the link.

Erika VavrovicovaTel: +421 232 660 382

Fax: +421 232 660 397
Email: erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com

Comments
Search RSS
Only registered users can write comments!

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!
 
< Prev   Next >
Advertisement
 

Featured Video

More videos ...

3D Content Cloud

Featured Partners

farmavita_research-store.gif
top-20-cancer-therapy-brand.jpg
generics-growth-strategies2.gif
sfe_eu10_150x150_v2.gif 
mddexeceu10_150x150_v1.gif
discovery2010_150x150.gif
150x150_salesonco-master.gif
pharma_omaeu10_150x150_v2.gif
risksharingnextlevel.gif 
arriello-150x150.gif 
150x150_ceepr3_master.gif 
pharmabrand2010_150x150.gif
 

Login to Farmavita.Net

membership is FREE

Follow us on:

bpe_oglas.gif




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 8 guests online

Farmavita.Net RSS News


Products

Click to Products

JobLine

Click here ...Post a Job for Free

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS